Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for www.osc.ca

Canadian Securities Regulators Disrupt Over 7,500 Fraudulent Investment Websites

Canadian securities regulators announced the disruption of over 7,586 fraudulent investment and crypto scam websites between June 2025 and February 2026. This initiative, part of Fraud Prevention Month, highlights ongoing efforts to protect investors from online fraud.

Priority review Notice Securities
Favicon for www.osc.ca

OSC, AMF, CIRO Approve Financial Services Platform Test

The Ontario Securities Commission (OSC), Autorité des marchés financiers (AMF), and Canadian Investment Regulatory Organization (CIRO) have approved Project Samara, a financial services platform test in Canada. This experimental project evaluates a distributed ledger technology platform for bond transactions, involving major financial institutions and the Bank of Canada.

Routine Notice Securities
16d ago FINTRAC Publications
Favicon for fintrac-canafe.canada.ca

FINTRAC Policy Interpretations for Proceeds of Crime Act

FINTRAC has updated its policy interpretations database concerning the Proceeds of Crime (Money Laundering) and Terrorist Financing Act. Notably, certain policy positions regarding payment processing and merchant servicing activities have been retracted as of April 27, 2022, with affected entities now subject to money services business requirements.

Routine Guidance Anti-Money Laundering
16d ago FINTRAC Publications
Favicon for fintrac-canafe.canada.ca

FINTRAC Interpretation Notices on Proceeds of Crime Law

The Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) has issued interpretation notices to clarify provisions of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act. These notices provide technical interpretations and plain language explanations for regulated entities, including accountants.

Routine Guidance Anti-Money Laundering
16d ago FINTRAC Publications
Favicon for fintrac-canafe.canada.ca

FINTRAC Guidance on Proceeds of Crime Act Obligations

FINTRAC has published updated guidance for reporting entities on their obligations under the Proceeds of Crime (Money Laundering) and Terrorist Financing Act. The guidance covers various sectors and key compliance areas such as client identification and transaction reporting.

Routine Guidance Anti-Money Laundering
16d ago FINTRAC Publications
Favicon for fintrac-canafe.canada.ca

FINTRAC Supervisory Framework Guidance

The Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) has released its supervisory framework. This guidance outlines the principles, risk framework, and pillars of supervision FINTRAC uses to ensure businesses comply with the Proceeds of Crime (Money Laundering) and Terrorist Financing Act.

Routine Guidance Anti-Money Laundering
16d ago FINTRAC Publications
Favicon for fintrac-canafe.canada.ca

FINTRAC Notices and Advisories for Reporting Entities

The Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) has issued numerous notices and advisories to reporting entities. These updates cover a range of obligations, including guidance on bribery and corruption, politically exposed persons, ministerial directives, and beneficial ownership reporting.

Priority review Notice Anti-Money Laundering
Favicon for recalls-rappels.canada.ca

Lifeworks Technology Massage Guns Recalled as Unauthorised Device

Health Canada has recalled Lifeworks Technology Vibra-Heal and Restore Massage Guns because they were distributed without a valid medical device licence. Sales have ceased, and the company plans to apply for the necessary licence.

Priority review Enforcement Medical Devices
Favicon for recalls-rappels.canada.ca

Olympus MAJ-1443 and MAJ-1444 Valves Recall

Health Canada has issued a Type II recall for Olympus MAJ-1443 and MAJ-1444 valves. These valves are no longer compatible with OER-Pro and OER-Elite automated endoscope reprocessors and require reprocessing via updated instructions. Healthcare providers should contact the manufacturer for further information.

Priority review Notice Medical Devices
Favicon for recalls-rappels.canada.ca

Health product recall: APO-BRIMONIDINE-TIMOP weight out of specification

Health Canada has issued a recall for APO-BRIMONIDINE-TIMOP due to a weight specification issue in lot VK2312. The recall is classified as Type II, indicating a low probability of adverse health consequences. Retailers are instructed to remove the affected product from shelves.

Urgent Notice Product Safety

Showing 14511–14520 of 18,996 changes

1 1450 1451 1452 1453 1454 1900

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.